Ligand validation:8YPY

HSX: 5-O-phosphono-alpha-D-ribofuranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8YPY_HSX_F_2001	20%	4%	0.153	0.752	2.34	3.16	9	12	9	0	100%	1
8YPY_HSX_B_2001	16%	32%	0.175	0.743	1.37	1.32	2	2	2	0	100%	1
8YPY_HSX_A_1002	15%	6%	0.166	0.726	2.04	3.04	8	13	2	0	100%	1
8YPY_HSX_E_1002	14%	22%	0.155	0.705	1.41	1.84	2	9	3	0	100%	1
8YPY_HSX_C_1003	3%	42%	0.195	0.535	1.26	1.01	1	1	0	0	100%	1
8YPY_HSX_D_1002	1%	40%	0.197	0.383	1.2	1.12	1	2	7	0	100%	1
8YQ0_HSX_O_1001	100%	56%	0.042	0.982	0.77	0.94	-	-	4	0	100%	1
5VN4_HSX_A_302	99%	62%	0.06	0.987	0.71	0.76	-	-	0	0	100%	1
1ZN7_HSX_A_506	98%	54%	0.065	0.987	0.79	0.97	-	-	1	0	100%	0.5
9MF6_HSX_C_501	97%	74%	0.054	0.968	0.48	0.54	-	-	0	0	100%	1
9DT7_HSX_B_302	96%	67%	0.063	0.971	0.48	0.79	-	1	0	0	100%	0.65
4L51_HSX_B_401	95%	0%	0.071	0.973	6.07	3.26	10	8	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.